These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Thiostrepton: A Novel Therapeutic Drug Candidate for Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481 [No Abstract] [Full Text] [Related]
7. A Novel Therapeutic Approach Using Mesenchymal Stem Cells to Protect Against Mycobacterium abscessus. Kim JS; Cha SH; Kim WS; Han SJ; Cha SB; Kim HM; Kwon KW; Kim SJ; Choi HH; Lee J; Cho SN; Koh WJ; Park YM; Shin SJ Stem Cells; 2016 Jul; 34(7):1957-70. PubMed ID: 26946350 [TBL] [Abstract][Full Text] [Related]
8. Mycobacterium abscessus Opsonization Allows an Escape from the Defensin Bactericidal Action in Touré H; Durand N; Guénal I; Herrmann JL; Girard-Misguich F; Szuplewski S Microbiol Spectr; 2023 Aug; 11(4):e0077723. PubMed ID: 37260399 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterium abscessus resists the innate cellular response by surviving cell lysis of infected phagocytes. Touré H; Galindo LA; Lagune M; Glatigny S; Waterhouse RM; Guénal I; Herrmann JL; Girard-Misguich F; Szuplewski S PLoS Pathog; 2023 Mar; 19(3):e1011257. PubMed ID: 36972320 [TBL] [Abstract][Full Text] [Related]
11. Treatment of infection-induced vascular pathologies is protective against persistent rough morphotype Mycobacterium abscessus infection in zebrafish. Kam JY; Wright K; Britton WJ; Oehlers SH Microb Pathog; 2022 Jun; 167():105590. PubMed ID: 35588967 [TBL] [Abstract][Full Text] [Related]
12. IgA Serological Response for the Diagnosis of Mycobacterium abscessus Infections in Patients with Cystic Fibrosis. Le Moigne V; Roux AL; Mahoudo H; Christien G; Ferroni A; Dumitrescu O; Lina G; Bouchara JP; Plésiat P; Gaillard JL; Canaan S; Héry-Arnaud G; Herrmann JL Microbiol Spectr; 2022 Jun; 10(3):e0019222. PubMed ID: 35583329 [TBL] [Abstract][Full Text] [Related]
13. The Diverse Cellular and Animal Models to Decipher the Physiopathological Traits of Bernut A; Herrmann JL; Ordway D; Kremer L Front Cell Infect Microbiol; 2017; 7():100. PubMed ID: 28421165 [No Abstract] [Full Text] [Related]
14. Type I interferon induced by TLR2-TLR4-MyD88-TRIF-IRF3 controls Mycobacterium abscessus subsp. abscessus persistence in murine macrophages via nitric oxide. Ruangkiattikul N; Rys D; Abdissa K; Rohde M; Semmler T; Tegtmeyer PK; Kalinke U; Schwarz C; Lewin A; Goethe R Int J Med Microbiol; 2019 Jul; 309(5):307-318. PubMed ID: 31178418 [TBL] [Abstract][Full Text] [Related]
15. Rapid detection and immune characterization of Mycobacterium abscessus infection in cystic fibrosis patients. Steindor M; Nkwouano V; Mayatepek E; Mackenzie CR; Schramm D; Jacobsen M PLoS One; 2015; 10(3):e0119737. PubMed ID: 25742660 [TBL] [Abstract][Full Text] [Related]
16. Lsr2, a pleiotropic regulator at the core of the infectious strategy of Gerges E; Rodríguez-Ordoñez MdP; Durand N; Herrmann J-L; Crémazy F Microbiol Spectr; 2024 Mar; 12(3):e0352823. PubMed ID: 38353553 [No Abstract] [Full Text] [Related]
17. Type I Interferons Are Involved in the Intracellular Growth Control of Ahn JH; Park JY; Kim DY; Lee TS; Jung DH; Kim YJ; Lee YJ; Lee YJ; Seo IS; Song EJ; Jang AR; Yang SJ; Shin SJ; Park JH Front Immunol; 2021; 12():738070. PubMed ID: 34777348 [No Abstract] [Full Text] [Related]
18. Antimicrobial properties of basidiomycota macrofungi to Millar BC; Nelson D; Moore RE; Rao JR; Moore JE Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186 [TBL] [Abstract][Full Text] [Related]
19. Silencing essential gene expression in Boudehen Y-M; Tasrini Y; Aguilera-Correa JJ; Alcaraz M; Kremer L Microbiol Spectr; 2023 Dec; 11(6):e0283623. PubMed ID: 37831478 [No Abstract] [Full Text] [Related]